Patent details

Basic Information

Publication number:

EP3263601

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP171822430

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION OF ANTI-KIR ANTIBODIES AND ANTI-PD-1 ANTIBODIES TO TREAT CANCER

French Title of Invention:

COMBINAISON D'ANTICORPS ANTI-KIR ET ANTI-PD-1 POUR TRAITER LE CANCER

German Title of Invention:

KOMBINATION AUS ANTI-KIR-ANTIKÖRPERN UND PD-1-ANTIKÖRPERN ZUR BEHANDLUNG VON KREBS

SPC Number:

Dates

Filing date:

02/10/2013

Grant date:

24/11/2021

EP Publication Date:

03/01/2018

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/11/2021

EP B1 Publication Date:

24/11/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

02/10/2022

Expiration date:

02/10/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/11/2021

 

 

Name:

Bristol-Myers Squibb Company

Address:

Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)

Inventor

1

Name:

GRAZIANO, Robert F.

Address:

United States (US)

2

Name:

WIGGINTON, Jon

Address:

United States (US)

3

Name:

KIM, Su Young

Address:

United States (US)

4

Name:

GUPTA, Ashok, K.

Address:

United States (US)

Priority

Priority Number:

201261708784 P

Priority Date:

02/10/2012

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/28; A61K 39/395; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202147

Publication date:

24/11/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages